📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes. (2021)

First Author: Davidson K

Attributed to: Unravelling the Mechanism of the Lung Tumour Suppressor LIMD1 from Cellular Metabolism to Malignant Transformation. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41419-021-04355-7

PubMed Identifier: 34764236

Publication URI: http://europepmc.org/abstract/MED/34764236

Type: Journal Article/Review

Volume: 12

Parent Publication: Cell death & disease

Issue: 11